6533b824fe1ef96bd12815e8
RESEARCH PRODUCT
Survey of Fertility Preservation Options Available to Patients With Cancer Around the Globe
Alexandra S. RashediSeok Hyun KimOsama AzmyNao SuzukiMario VegaMahmoud SalamaSeido TakaeLauren M. AtamanRicardo Mello MarinhoJoão Marcos De Meneses E SilvaMaría Del Mar AndrésJose MedranoEllen Van MoerMaxwell E EdmondsPaulo Henrique Almeida Campos-juniorAyse ArvasLudwig WildtWillianne L.d.m. NelenMaurício Barbour ChehinYodo SugishitaAdelino Amaral SilvaJhenifer Kliemchen RodriguesCesar Diaz-garciaClaus Yding AndersenMohamed KhroufJohan SmitzRoberto De A AntunesRicardo AzambujaFlor SánchezRod T. MitchellSaskia F De RooElnaz ZandRichard A. AndersonRobert JachYasmin JayasingheTeresa Almeida-santosPeter MallmannSergio RomeroLígia Helena Ferreira Melo E SilvaTalya ShaulovGuillermo TerradoSatish Kumar AdigaTatsuro FuruiCassio SartorioPaula FontouraKristin SmithMichel De VosAntoinette AnazodoSilvana Chedid GriecoCláudia MeloChang Suk SuhAnna HorbaczewskaFernando M. ReisJung Ryeol LeeCatharina C. M. BeerendonkKatharina Winkler-crepazEllen M. GreenblattAnibal ScarellaRouhollah FathiMaria T BourlonTeresa K. WoodruffEduardo Marchetti Pereira Leão Da MottaBruno Ramalho De Carvalhosubject
Cancer Researchmedicine.medical_specialtyReferralmedia_common.quotation_subjectBest practiceMEDLINEFertilitylcsh:RC254-282Cost EffectivenessFertilidade03 medical and health sciences0302 clinical medicineSupportive Care and Quality of LifeJournal ArticleQuality of CareMedicineFertility preservationmedia_commonOncofertilityEthicsMedicine(all)Response rate (survey)030219 obstetrics & reproductive medicinebusiness.industryHealth Services and OutcomesORIGINAL REPORTSlcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensSupportive CarePolicy AnalysisWomen's cancers Radboud Institute for Health Sciences [Radboudumc 17]3. Good healthFertilityOncology030220 oncology & carcinogenesisFamily medicineScale (social sciences)Quality of Life/dk/atira/pure/researchoutput/pubmedpublicationtype/D016428businessdescription
Purpose Oncofertility focuses on providing fertility and endocrine-sparing options to patients who undergo life-preserving but gonadotoxic cancer treatment. The resources needed to meet patient demand often are fragmented along disciplinary lines. We quantify assets and gaps in oncofertility care on a global scale. Methods Survey-based questionnaires were provided to 191 members of the Oncofertility Consortium Global Partners Network, a National Institutes of Health–funded organization. Responses were analyzed to measure trends and regional subtleties about patient oncofertility experiences and to analyze barriers to care at sites that provide oncofertility services. Results Sixty-three responses were received (response rate, 25%), and 40 were analyzed from oncofertility centers in 28 countries. Thirty of 40 survey results (75%) showed that formal referral processes and psychological care are provided to patients at the majority of sites. Fourteen of 23 respondents (61%) stated that some fertility preservation services are not offered because of cultural and legal barriers. The growth of oncofertility and its capacity to improve the lives of cancer survivors around the globe relies on concentrated efforts to increase awareness, promote collaboration, share best practices, and advocate for research funding. Conclusion This survey reveals global and regional successes and challenges and provides insight into what is needed to advance the field and make the discussion of fertility preservation and endocrine health a standard component of the cancer treatment plan. As the field of oncofertility continues to develop around the globe, regular assessment of both international and regional barriers to quality care must continue to guide process improvements.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2020-03-01 |